We are live on
!
Find out more
ADIM
Alpha DNA Investment Management Portfolio holdings
AUM
$8.98M
1-Year Est. Return
26.05%
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$244M
AUM Growth
-$55.3M
(-18%)
Cap. Flow
-$44.9M
Cap. Flow
% of AUM
-18.39%
Top 10 Holdings %
Top 10 Hldgs %
47.87%
Holding
229
New
82
Increased
25
Reduced
61
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$2.17M |
| 2 |
Philip Morris
PM
|
+$1.84M |
| 3 |
Colgate-Palmolive
CL
|
+$1.83M |
| 4 |
RTX Corp
RTX
|
+$1.82M |
| 5 |
Procter & Gamble
PG
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.5M |
| 2 |
Coca-Cola
KO
|
+$1.81M |
| 3 |
Merck
MRK
|
+$1.72M |
| 4 |
Accenture
ACN
|
+$1.23M |
| 5 |
ExxonMobil
XOM
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.37% |
| 2 | Healthcare | 12.44% |
| 3 | Financials | 8.73% |
| 4 | Consumer Staples | 6.45% |
| 5 | Industrials | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Camtek
CAMT
$7.67B
| $573K | 0.23% |
+9,207
| New | +$455K |
|
|
IMGN
102
DELISTED
Immunogen Inc
IMGN
| $570K | 0.23% |
+35,896
| New | +$597K |
|
103
Wayfair
W
$14.1B
| $567K | 0.23% |
+9,369
| New | +$651K |
|
104
Xencor
XNCR
$1.64B
| $566K | 0.23% |
+28,075
| New | +$638K |
|
105
Procore
PCOR
$8.93B
| $565K | 0.23% |
8,652
-4,282
| -33% | -$286K |
|
106
Sixth Street Specialty
TSLX
$1.78B
| $565K | 0.23% |
27,626
-11,435
| -29% | -$228K |
|
107
Neurocrine Biosciences
NBIX
$16.5B
| $562K | 0.23% |
+4,993
| New | +$526K |
|
|
BCYC
108
Bicycle Therapeutics
BCYC
$288M
| $562K | 0.23% |
+27,957
| New | +$639K |
|
109
ANI Pharmaceuticals
ANIP
$1.71B
| $559K | 0.23% |
9,627
-4,093
| -30% | -$236K |
|
110
Nutanix
NTNX
$17.4B
| $558K | 0.23% |
15,997
-13,349
| -45% | -$419K |
|
111
Beazer Homes USA
BZH
$874M
| $554K | 0.23% |
+22,251
| New | +$642K |
|
112
Sprinklr
CXM
$1.61B
| $553K | 0.23% |
+39,976
| New | +$573K |
|
113
Delek US
DK
$3.92B
| $550K | 0.22% |
+19,344
| New | +$522K |
|
|
TAST
114
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $549K | 0.22% |
+83,354
| New | +$513K |
|
115
e.l.f. Beauty
ELF
$5.61B
| $548K | 0.22% |
4,989
-2,556
| -34% | -$310K |
|
116
Toast
TOST
$20.2B
| $548K | 0.22% |
+29,247
| New | +$635K |
|
117
Customers Bancorp
CUBI
$2.8B
| $547K | 0.22% |
15,877
-13,592
| -46% | -$491K |
|
118
Amplitude
AMPL
$1.59B
| $544K | 0.22% |
+46,991
| New | +$544K |
|
119
Trex
TREX
$5.07B
| $540K | 0.22% |
+8,769
| New | +$602K |
|
120
Coty
COTY
$2.48B
| $540K | 0.22% |
49,224
-13,235
| -21% | -$156K |
|
121
Applovin
APP
$107B
| $540K | 0.22% |
+13,509
| New | +$479K |
|
122
Preferred Bank
PFBC
$1.27B
| $539K | 0.22% |
+8,652
| New | +$540K |
|
123
uniQure
QURE
$3.12B
| $534K | 0.22% |
79,611
+16,786
| +27% | +$151K |
|
124
Fortune Brands Innovations
FBIN
$5.97B
| $534K | 0.22% |
+8,587
| New | +$590K |
|
125
Legend Biotech
LEGN
$4.22B
| $533K | 0.22% |
7,933
-1,911
| -19% | -$133K |
|
Similar funds
CAWM
AI
PC
CP
AVM
CSD
NP
BPWM
Alpha DNA Investment Management's Q3 2023 Portfolio in Review
As of Q3 2023, Alpha DNA Investment Management held 229 positions worth $244M, down 18% from $300M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Alpha DNA Investment Management withdrew a net $44.9M in Q3 2023, closing 60 positions and reducing 61 holdings. Its most notable exit was Parker-Hannifin, an estimated $1.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Alpha DNA Investment Management opened a new position in Becton Dickinson worth $2.07M.
- Alpha DNA Investment Management's largest Q3 2023 buy was Becton Dickinson: 8,016 shares worth $2.07M.
- Alpha DNA Investment Management added most to Microsoft in Q3 2023, an estimated $1.03M increase.
- Alpha DNA Investment Management's biggest Q3 2023 reduction was Visa, cutting an estimated $2.5M.
- Alpha DNA Investment Management fully exited Parker-Hannifin in Q3 2023, selling an estimated $1.21M.
- Alpha DNA Investment Management's ten largest holdings make up 48% of its $244M portfolio in Q3 2023.
- Alpha DNA Investment Management opened 82 new positions and closed 60 in Q3 2023.
- Alpha DNA Investment Management's portfolio value fell 18% quarter-over-quarter to $244M.
Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.